150 results
8-K
ZNTL
Zentalis Pharmaceuticals Inc
11 Apr 24
Departure of Directors or Certain Officers
7:00am
Financial Officer. Ms. Epperly is eligible to receive severance benefits under her Amended & Restated Employment Agreement, dated February 28, 2023, which
8-K
EX-99.1
ZNTL
Zentalis Pharmaceuticals Inc
9 Apr 24
Regulation FD Disclosure
4:30pm
development and the potential benefits thereof, including in platinum sensitive ovarian cancer; the potential for our development approach in platinum … ; potential for generating datasets with value-creating potential; potential for combinations including our product candidates and the potential benefits
S-3ASR
EX-4.3
ZNTL
Zentalis Pharmaceuticals Inc
29 Feb 24
Automatic shelf registration
5:14pm
Series in respect of any matters, provided that all Series of Securities shall be equally and ratably entitled to the benefits of the Indenture … shall be at any time enforceable by anyone, and shall be entitled to all the benefits of this Indenture equally and proportionately with any and all
S-3ASR
EX-1.2
ZNTL
Zentalis Pharmaceuticals Inc
29 Feb 24
Automatic shelf registration
5:14pm
of Common Stock issuable upon the exercise of options or vesting of other securities, pursuant to any employee or director stock option or benefits plan … and the Agent may be subject in such proportion as shall be appropriate to reflect
the relative benefits received by the Company on the one hand
S-3ASR
egkj12ys2dnghquf2gg3
29 Feb 24
Automatic shelf registration
5:14pm
8-K
EX-99.1
4sod3 10ckmts3d29
27 Feb 24
Zentalis Pharmaceuticals Reports Full Year 2023 Financial Results and Operational Updates
7:04am
8-K
EX-3.1
odk71 af8ihtc
15 Feb 24
Amendments to Articles of Incorporation or Bylaws
4:12pm
8-K
znzpkn
25 Jan 24
Zentalis Pharmaceuticals Strengthens Management Team with Key Appointments
7:03am
8-K
EX-99.1
ksmqsj1pbjm1qgucn1tc
8 Jan 24
Regulation FD Disclosure
7:03am